中药制剂“肺炎一号合剂”联合抗生素治疗儿童社区获得性肺炎的临床效果

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of traditional Chinese medicine preparation "Pneumonia No.1 Mixture" combined with antibiotics on children′s community acquired pneumonia.Methods From October 2019 to March 2021,a total of 180 cases of children with community acquired pneumonia admitted to the First People′s Hospital of Hechi City were selected as the research objects and divided into the control group and the observation group by random number table method,with 90 cases in each group.Children in the control group were given Cefotaxime supplemented with Ambroxol Western medicine to reduce phlegm and relieve cough,while children in the observation group were combined with traditional Chinese medicine preparation "Pneumonia No.1 Mixture" on the basis of the control group.The therapeutic effect,clinical indicators and incidence of adverse reactions were compared between the two groups.Results The total incidence of adverse reactions in the observation group was 2.22%,which was lower than 10.00% of the control group,the difference was statistically significant(P＜0.05).The length of hospitalization,disappearance time of pulmonary rales and cough disappearance time in the observation group were shorter than those in the control group,and the differences were statistically significant(P＜0.05).The total effective rate of treatment in the observation group was 95.56%,which was higher than 86.67% of the control group,the difference was statistically significant(P＜0.05).Conclusion On the basis of conventional Western medicine treatment,the combination of "Pneumonia No.1 Mixture" in the treatment of children community acquired pneumonia can not only effectively improve the clinical efficacy,speed up the recovery of patients,but also reduce the incidence of adverse reactions.

Key words： Community acquired pneumonia in children Pneumonia No.1 Mixture Antibiotics Combination of Chinese and Western medicine Adverse drug reaction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEI You-jia
	WEI Hui-lian
	LI Ya-dian
	LU Ying-hua

Cite this article:

WEI You-jia,WEI Hui-lian,LI Ya-dian, et al. Clinical effect of traditional Chinese medicine preparation "Pneumonia No.1 Mixture" combined with antibiotics on children′s community acquired pneumonia[J]. 中国当代医药, 2021, 28(31): 150-152转156.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I31/150

[1]	儿童社区获得性肺炎诊疗规范（2019年版）[J].中华临床感染病杂志，2019（1）：6-13.
[2]	潘文桥.中西药联合治疗儿童社区获得性肺炎70例[J].中国中医药现代远程教育，2011，9（21）：117-118.
[3]	Harris M，Clark J，Coote N，et al.British Thoracic Society guidelines for the management of community acquired pneumonia in children[J].Thorax，2011，10（66）：1-23.
[4]	陈献军.喜炎平佐治儿童社区获得性肺炎的疗效及安全性探讨[J].中华全科医学，2015，13（4）：618-620.
[5]	Rudan I，El Arifeen S，Bhutta ZA，et al.Setting research priorities to reduce global mortality from childhood pneumonia by 2015[J].PLoS Med，2011，8（9）：e1001099.
[6]	曾子倩，朱彦峰，余小平.全球登革热流行病学概况及防控研究进展[J].成都医学院学报，2014，9（5）：526-532.
[7]	刘轶，张兰豫，孟作龙，等.5岁以下儿童社区获得性肺炎住院病例疾病负担调查分析[J].中国妇幼保健，2016，31（4）：810-811.
[8]	彭评志，蒙光义，莫金权，等.玉林市儿童新的和严重的药品不良反应报告分析[J].西北药学杂志，2017，32（4）：518-521.
[9]	马猛.2011年泰安市477例儿童药品不良反应回顾性分析[J].中国医院药学杂志，2013，33（2）：163-165.
[10]	孙定人，齐平，靳颖华.药物不良反应[M].3版.北京：人民卫生出版社，2003：10.
[11]	张吉艳，王磊，马骁龙，等.喹诺酮类抗菌药的应用效果、临床合理应用及不良反应分析[J].医学食疗与健康，2019，48（6）：96，104.
[12]	熊艳萍.头抱菌素类抗生素致不良反应的原因分析及其救治对策[J]抗感染药学，2016，13（3）：546-548.
[13]	彭红霞，袁雪萍.婴幼儿及儿童发生抗生素相关性腹泻的危险因素分析[J].中国民康医学，2019，31（2）：82-84.
[14]	庞永太.头孢菌素类抗生素不良反应的因素及对策[J].世界最新医学信息文摘，2013，13（19）：196-197.
[15]	张红果，吕娟丽，刘春梅.我院2010-2012年大环内酯类抗生素不良反应报告分析[J].武警后勤学院学报（医学版），2013，22（7）：636-637，640.
[16]	樊晓丽.2013-2014年儿童使用抗生素后420例血象分析[J].中国城乡企业卫生，2016，2（2）：32-33.
[17]	孔雪云，陈琦，吴祥，等.中西药联用相互作用研究进展[J]南京中医药大学学报，2018，34（1）：5-11.
[18]	达志河.宣白承气汤鼻饲联合西药治疗呼吸机相关性肺炎 82 例[J].西部中医药，2021，34（2）：89-92.
[19]	郭郡.加味二陈汤联合西药治疗老年社区获得性肺炎（痰湿阻肺证）的临床效果[J].中国医药科学，2021，11（3）：106-108.
[20]	吴霞，彭学铭.中西医结合治疗痰湿蕴肺型社区获得性肺炎的效果分析[J].中国当代医药，2021，28（3）：185-188.